Skip to content
ESPT
MARKETS / NASDAQ / Health care / Medical devices and instruments / PDEX
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

PRO DEX Inc. PDEX

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$77.5M
▲ 16.5% YoY
$13.7M
▲ 52.2% YoY
$6.8M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. It also manufactures and sells rotary air motors to a wide range of industries, though these motors comprise a de minimis portion of its business. The majority of its revenue is derived from designing, developing and manufacturing surgical devices for the medical device industry. The company has only one operating segment as its business is currently operated. Its principal headquarters are located at 2361 McGaw Avenue, Irvine, California, and it also operates a facility in Tustin, California. At June 30, 2025 and 2024, the company had 181 and 148 employees, respectively, two of whom were part time, and all were working at one or both of its facilities in Irvine, California and Tustin, California.

Written from the business description in PRO DEX INC's annual report to the U.S. Securities and Exchange Commission, filed 4 September 2025. Every sentence was checked against that document before publication.

Growth

USD 77.5M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 77.5 · Net income 13.7
30M60M
201020132016201920222025
Compound annual growth
+18.9%
+15.3%
+15.0%
+8.1%
+24.5%
+17.2%
+32.5%
+11.6%
+28.3%
+21.3%
+35.3%
+11.5%
+30.1%
−9.3%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.3% a year over the five years to FY2025 — but profit grew faster: net income at +17.2%, earnings per share at +21.3%.

The share count fell from 0.00B to 0.00B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

0 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 16.8% · Net 0.0%
10%20%-5%-10%-15%
201020172025
ROE
FY2025 · ROE 32.4%
20%40%-10%-20%
201020172025
Three returns, three denominators.
Gross margin31.4%
Operating margin16.8%
Net margin0.0%
EBITDAUSD 14.4M

Each USD of equity produced 32 cents of profit this year.

Cash & shareholders

USD 3.4M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 6.8
2.5M5.0M-1.5M-3.0M
201020172025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 3.4
2M4M-1M-2M
2011201520172019202120232025
Dividends paid·
Net buybacksUSD 3.4M
Share of profit24.9%
Consecutive raises·

USD 3.4M in buybacks — 25% of the year's profit went back to shareholders.

Total assetsUSD 74.5M
EquityUSD 47.6M
CashUSD 8.2M
Gross debtUSD 17.5M
Net debtUSD 9.3M
Current ratio4.10×

Net debt stands at 20% of equity.

The 16-year record

16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
PDEX, 16-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.00.00.00.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
Income tax $B0.00.00.00.00.00.00.00.00.0−0.00.0−0.0−0.0−0.0−0.00.0
Net income $B0.00.00.00.00.00.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
Free cash flow $B0.0−0.0◌◌−0.0−0.00.00.00.00.00.0−0.0−0.0−0.0−0.00.0
EPS, diluted $4.122.670.601.951.211.571.500.970.371.250.20−0.09−0.14−0.54−0.270.80
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————————
ROE %32.426.66.824.819.630.733.924.210.545.09.5−4.1−5.7−20.4−8.825.6
Shares out B0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY
Provenance

Company facts, as filed

How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 16 of the 16 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated innot stated in the filings
Fiscal year endsJune 30
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image